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CASE REPORT Open Access
Vertebral defect, anal atresia, cardiac
defect, tracheoesophageal fistula/
esophageal atresia, renal defect, and limb
defect association with Mayer-Rokitansky-
Küster-Hauser syndrome in co-occurrence:
two case reports and a review of the
literature
Thomas Bjørsum-Meyer1,2*, Morten Herlin3, Niels Qvist1,2 and Michael B. Petersen3,4
Abstract
Background: The vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/esophageal atresia, renal
defect, and limb defect association and Mayer-Rokitansky-Küster-Hauser syndrome are rare conditions. We aimed to
present two cases with the vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/esophageal
atresia, renal defect, and limb defect association and Mayer-Rokitansky-Küster-Hauser co-occurrence from our local
surgical center and through a systematic literature search detect published cases. Furthermore, we aimed to collect
existing knowledge in the embryopathogenesis and genetics in order to discuss a possible link between the
vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/esophageal atresia, renal defect, and limb
defect association and Mayer-Rokitansky-Küster-Hauser syndrome.
Case presentation: Our first case was a white girl delivered by caesarean section at 37 weeks of gestation; our
second case was a white girl born at a gestational age of 40 weeks. A co-occurrence of vertebral defect, anal
atresia, cardiac defect, tracheoesophageal fistula/esophageal atresia, renal defect, and limb defect association and
Mayer-Rokitansky-Küster-Hauser syndrome was diagnosed in both cases.
We performed a systematic literature search in PubMed ((VACTERL) OR (VATER)) AND ((MRKH) OR (Mayer-Rokitansky-
Küster-Hauser) OR (mullerian agenesis) OR (mullerian aplasia) OR (MURCS)) without limitations. A similar search was
performed in Embase and the Cochrane library. We added two cases from our local center.
All cases (n = 9) presented with anal atresia and renal defect. Vertebral defects were present in eight patients.
Rectovestibular fistula was confirmed in seven patients. Along with the uterovaginal agenesis, fallopian tube aplasia
appeared in five of nine cases and in two cases ovarian involvement also existed.
(Continued on next page)
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Conclusions: The co-occurrence of the vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/
esophageal atresia, renal defect, and limb defect association and Mayer-Rokitansky-Küster-Hauser syndrome is
extremely rare. This group of patients has unusual phenotypic characteristics. The long-term outcome after treatment
of defects is not well reported. A single unifying cause is not known and the etiology probably includes both genetic
and non-genetic causes. We stress the importance of future studies to optimized treatment, follow-up, and etiology.
Keywords: Congenital abnormalities, Syndrome association, VACTERL association, Mullerian aplasia, Rare diseases
Background
The vertebral defect, anal atresia, cardiac defect, tra-
cheoesophageal fistula/esophageal atresia, renal defect,
and limb defect (VACTERL) association and Mayer-
Rokitansky-Küster-Hauser (MRKH) syndrome are rare
conditions. The co-occurrence of the VACTERL associ-
ation and MRKH syndrome is extremely rare and has
only been casuistically reported. Even with optimal sur-
gical corrections of malformations, patients affected by
the VACTERL association can face medical challenges
throughout life such as back pain (scoliosis), fecal incon-
tinence (anal atresia, AA), and functional impairment
(limb anomalies) [1]. The medical challenges are highly
dependent on type and severity of the specific malforma-
tion. Women affected by the MRKH syndrome are
unable to bear children and the syndrome may have a
long-lasting negative impact on their level of psycho-
logical distress and self-esteem [2]. Reporting cases of
rare conditions is important to expand knowledge on
possible etiological factors, treatment, and outcome. We
have treated two patients at our center with the VAC-
TERL association and MRKH co-occurrence, which add
further knowledge to the condition. To the best of our
knowledge a possible embryologic or genetic cause in
the development of the VACTERL association and
MRKH syndrome has not been addressed in the litera-
ture so far. We aimed to collect existing knowledge in
embryopathogenesis and genetics in order to discuss a
possible link between two rare disease entities.
Our objectives were:
– To present two cases with the co-occurrence of the
VACTERL association and the MRKH syndrome
from our surgical center.
– To perform a systematic review of the literature to
detect cases with the co-occurrence of the VACTERL
association and the MRKH syndrome in order to
characterize patients regarding clinical presentation,
outcome, and treatment.
– To discuss possible embryopathogenesis and
genetics in patients with the co-occurrence of the
VACTERL association and the MRKH syndrome.
VACTERL association
VACTERL association (Online Mendelian Inheritance in
Man, OMIM, 192350) is the co-occurrence of birth
defects including vertebral defect, AA, cardiac defect,
tracheoesophageal fistula (TEF)/esophageal atresia, ra-
dial and renal dysplasia, and limb defects. It is generally
accepted that the diagnostic criteria are the occurrence
of at least three of the mentioned birth defects. The
prevalence has been estimated to be 1:10,000 to 1:40,000
in live births [3–5]. Most cases of VACTERL appear
sporadic although familial occurrence has been de-
scribed. Genetic factors have been proposed but so far
no single gene mutation or chromosomal anomaly has
been identified as the unifying cause [6]. Vertebral
anomalies have been reported in 60 to 80% of patients
[7–12] and are often accompanied by rib anomalies.
Typical vertebral anomalies are hemivertebrae, vertebral
fusions, and supernumerary or absent vertebrae. There
was a great variety in the reports of the severity of verte-
bral malformations [9, 12]. A common clinical presenta-
tion is scoliosis [13]. AA is reported in 55 to 90% of
patients with VACTERL association [7–11]. In contrast
to vertebral anomalies, AA is often recognized during
the immediate clinical examination after birth. In more
subtle cases AA may present later as constipation, which
appears in up to 21% of the patients [14]. Some clinicians
require an imperforate anus to address it as a VACTERL
association while others allow minor AA to be included.
Cardiac malformations are also common and observed in
40 to 80% of patients [9–11]. They range from life-
threatening malformations, which require complicated
surgical procedures, to small asymptomatic defects which
are discovered incidentally [10, 11, 13]. A persistent
ductus arteriosus and foramen ovale should not be regis-
tered as a defect in the VACTERL association [1]. TEF is
reported in 50 to 80% of patients with VACTERL [7–11].
TEF is a potentially life-threating condition and often
requires surgery in the first few days of life. The preva-
lence of renal malformations is 50 to 80%, of which there
is a great variation in severity [8–11]. They present as
horseshoe kidney, cystic kidney, dysplastic kidney, or
unilateral or bilateral agenesis. Limb anomalies are
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traditionally defined as radial anomalies including
aplasia/hypoplasia of the thumb. Other limb anomal-
ies have also been described, for example anomalies
of lower extremities. They are reported in 40 to 50%
of patients with VACTERL [3, 7, 8, 10, 12, 15]. The
first sign of the VACTERL association may be the
presence of a single umbilical artery diagnosed pre-
natally and this finding should lead to a comprehen-
sive examination for other defects in the VACTERL
association [16, 17].
MRKH syndrome
MRKH syndrome (OMIM 277000) is a congenital dis-
order of the Müllerian ducts, characterized by agene-
sis or aplasia of the uterus and upper two-thirds of
the vagina in females with normal secondary sex
characteristics (thelarche and pubarche) and a normal
karyotype (46,XX) [18]. Prevalence has been estimated
to be 1 in 5000 live female births [19, 20] and MRKH
syndrome is considered the second most common
cause of primary amenorrhea after ovarian failure
[21]. Patients typically present in their adolescence
with complaints of primary amenorrhea; however,
other complaints include lower abdominal pain, dys-
pareunia, and infertility. MRKH syndrome is classified
into three groups [22]: type I/typical MRKH is char-
acterized by isolated uterovaginal agenesis, type II/
atypical MRKH is associated with renal and ovarian
malformations, and the third type is Müllerian duct
aplasia, renal aplasia, and cervicothoracic somite dys-
plasia (MURCS; OMIM 601076) association with
renal, skeletal, and cardiac malformations, and hearing
impairment. However, the definition and application of
this classification in the literature are still inconsistent.
The cause(s) of MRKH syndrome still remains unknown.
Reports of discordance in monozygotic twins have sug-
gested a non-genetic etiology. Previously, diethylstilbestrol
(DES) and thalidomide were suspected as possible terato-
genic causes [23, 24]; however, increasing reports of famil-
ial occurrence of MRKH syndrome and its associated
extragenital malformations [25] have led to several investi-
gations searching for a genetic etiology. Most studies con-
ducted so far have found no clear association. Mutations
in the WNT4 gene have been associated with uterovaginal
agenesis in virilized females [26] – an entity believed to be
different from the MRKH syndrome. The management
of MRKH syndrome involves counselling about the
functional and psychosexual impacts and the creation
of a neovagina in order to allow sexual intercourse.
The American College of Obstetricians and Gynecolo-
gists (ACOG) recommends vaginal dilatation as first
choice therapy due its few complications, but several
other surgical procedures are also being used [27].
Case presentation
Patient medical report – case 1
A white girl was delivered by caesarean section at
37 weeks of gestation due to suspected mechanical dis-
proportions. Her family history was without known in-
born abnormalities and consanguinity. Her birthweight
was 2600 g and her Apgar scores were 10/1 and 10/5. A
physical examination revealed AA. An analysis of the
prenatal amniotic fluid showed a normal female karyo-
type. Prenatal ultrasound (US) showed left-sided renal
cysts and a TEF was suspected. Plain X-ray indicated
esophageal atresia with TEF and high AA. Meconium
was observed from her vaginal introitus. A colostomy
was opened during her first day of life together with an
end-to-end anastomosis of her esophagus and closure of
the TEF. Ultrasonography during her fifth day of life
showed a left hydronephrosis and three communicating
renal cysts with a normal right kidney. A renography
performed at 2 years of age showed no function of her
left kidney. A late posterior sagittal anorectoplasty
(PSARP) was performed when she was 3-years old. Peri-
operatively a vaginal aplasia was found and no uterus
was found. Two months after the PSARP the colostomy
was closed and a left nephrectomy performed. She de-
veloped a thoracolumbar scoliosis confirmed by a com-
puted tomography (CT) scan (Fig. 1) which was
corrected during childhood and adolescence through
several operations. At the age of 15 years vaginal dila-
tions treatment was started. At 20 years of age she was
admitted to hospital with lower abdominal pain. A trans-
vaginal US showed an abscess at her vaginal top, which
was treated with transvaginal drainage and antibiotics.
The following 4 weeks were uneventful and it was de-
cided to attempt a surgical extension of her vagina. The
procedure was complicated by a lesion of her bladder
neck which was treated conservatively with a urethral
catheter for 4 weeks without further complications. A
magnetic resonance (MR) scan afterwards showed no
restoration of the abscess. Her left ovary was absent and
her fallopian tube appeared rudimentary on the left side.
A normal ovary was documented on her right side. In
2015 at the age of 22 years a new attempt at dilations
was made, which was now preceded by a small incision
at the top of her vaginal pouch. The dilation treatment
resulted in an 8 cm-long vagina.
She fulfilled the criteria for VACTERL association with
vertebral anomalies, AA, TEF, and kidney defect. Her
diagnostic criteria for MRKH syndrome were aplasia of
the vagina, absent uterus, and a multicystic dysplastic
left kidney.
Patient medical report – case 2
A white girl born at a gestational age of 40 weeks with a
birthweight of 3088 g presented with AA (Fig. 2) and a
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fistula opening near her vaginal introitus. Her family
history was without known inborn abnormalities and
consanguinity. Her Apgar scores were 8, 9, and 10 after
1, 5, and 10 minutes respectively. The pregnancy was
uneventful. A diverging colostomy was created at 11 days
of age. Perioperatively a remnant of vagina was found
and the uterus was absent. Normal fallopian tubes and
ovaries were demonstrated on both sides. A duplex kid-
ney was found on her right side with hydroureter. A se-
vere sacral dysgenesis was suspected clinically. She had a
normal karyotype. PSARP was performed at the age of
4 months. After 6 months the colostomy was closed. A
MR scan at 21 months of age revealed a tethered spinal
cord and an intradural lipoma from L4 to S2.
Despite dietary restrictions and laxatives our patient
had chronic constipation and an appendicostomy for
antegrade colonic enema was created at 7 years of age.
She continued to have abdominal pain, nausea, and
vomiting. A sigmoidoscopy showed a siphon-like config-
uration at her colonic anastomosis; therefore, it was
decided to perform a resection of her anastomotic colon,
which was complicated by anastomotic leakage necessi-
tating an intermittent diverting colostomy.
Her criteria for the VACTERL association were teth-
ered cord and sacral scoliosis, AA, and duplex kidney.
Absent uterus and proximal vaginal agenesis were diag-
nostic for MRKH syndrome.
Discussion
Search strategy and data collection
A literature search was conducted in the PubMed data-
base using the following search terms: ((VACTERL) OR
(VATER)) AND ((MRKH) OR (Mayer-Rokitansky-Küster-
Hauser) OR (mullerian agenesis) OR (mullerian aplasia)
OR (MURCS)) from inception to 18 September 2015
(Fig. 3) without limitations. A similar literature search was
performed in Embase and the Cochrane Library. Further-
more a reference search was made. Identified cases are
shown in Table 1. Three authors were contacted regarding
further information on their cases and one responded. To
be included, the cases had to meet the diagnostic criteria
for both the VACTERL association and MRKH syndrome
and not fulfill the criteria for other syndromes or associa-
tions. Karyotype had to be normal but we also included
cases without information on karyotype.
Diagnostic criteria for the VACTERL association: ≥3 of
the following: vertebral defect, AA, cardiac defect, TEF/
esophageal atresia, renal defect, and limb defect.
Diagnostic criteria for MRKH syndrome: agenesis of
the upper vagina and uterus.
Quality assessment of case reports
The transparency and accuracy of included case reports
were assessed using the CARE checklist [28]. Each of the
Fig. 2 Case 2 (6-days old), clinical photograph of the patient in
the supine position showing an absent anus. Fistula opening is
not presented
Fig. 1 Case 1, computed tomography reconstruction of the spine
showing a thoracolumbar scoliosis
Bjørsum-Meyer et al. Journal of Medical Case Reports  (2016) 10:374 Page 4 of 10
14 items included in the CARE checklist was denoted
either 0 =missing, 1 = fair, 2 = good or not applicable. A
total score of <50% of a possible maximum was denoted
poor, 50 to 74% = fair and ≥75% = good. Two of the in-
cluded cases were not described in case reports and the
CARE checklist was therefore not applicable. Of the five
quality assessed case reports, four were estimated as fair
whereas one case report was estimated as poor.
Demographics and clinical presentation
Six of the seven case reports were published in the
twenty-first century whereas one study was published in
1977. Most studies (n = 5) were European, one was from
Asia, and one was from USA.
A single umbilical artery was not described in any of
the nine cases.
In all cases (n = 9) reported with the VACTERL associ-
ation and MRKH syndrome anorectal malformations
and renal defects were present (Table 1). In all but one
case, a vertebral defect was detected. In one case all
features of the VACTERL association were present.
Numbers of involved VACTERL components varied
from three to all six components. In seven patients a
rectovestibular fistula was present.
Along with the uterovaginal agenesis, fallopian tube
aplasia appeared in five of nine cases and in two cases
there was also ovarian involvement. Associated anomal-
ies were described in six out of nine cases.
Surgical approach
PSARP was the preferred surgical technique for repair of
anorectal malformations; it was applied in six out of nine
patients. In one patient an anterior sagittal anorecto-
plasty (ASARP) was preferred. The surgical techniques
for uterovaginal malformations were sigmoid loop va-
ginoplasty (N = 2), modified Vecchietti, and vaginal dila-
tions. Two patients died within the first 3 months of life
and no surgical repair performed.
Conclusions
Clinical presentation and treatment strategies
All included cases with the VACTERL association and
MRKH syndrome presented with AA. Totonelli et al.
assessed the outcome in patients with AA as part of the
VACTERL association (VACTERL+) [29]. In 174 patients
Records identified through database searching
(Pubmed n = 30)  
(Embase n = 26)
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Additional records identified through 
reference search (n = 7)
Records after duplicates removed
(n = 41) 
Records screened
(n = 41) 
Records excluded by title and 
abstract
(n=21)
Full-text articles assessed for 
eligibility
(n = 20) 
Full-text articles excluded
Diagnostic criteria not met(n =13)
Studies included in qualitative 
synthesis
(n = 7)
Studies included in quantitative 
synthesis 
(n = 7) 
Fig. 3 Flow diagram of record selection
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with AA, 31 (18%) patients fulfilled criteria for the
VACTERL association. Rectovestibular fistula was
present in seven (23%) of these patients (VACTERL+)
which was similar to patients without VACTERL. The
poorer functional outcome in patients with VACTERL+
might be related to a higher incidence of spinal anom-
alies. In all cases reported with coexisting VACTERL
and MRKH, AA was present and eight out of nine cases
also had a vertebral defect.
In a cohort of 346 patients with MRKH syndrome, Rall
et al. only found the presence of AA in three patients
whereas one patient presented with the VACTERL asso-
ciation [30]. The high incidence of AA in patients who
presented with the co-occurrence of the VACTERL asso-
ciation and MRKH syndrome is in accordance with the
high incidence of AA in patients with VACTERL. The
recommended surgical technique for repair of anorectal
malformations with rectovestibular fistula is a PSARP,
which is reported to have an excellent functional out-
come in highly specialized centers and no associated de-
fects [31]. According to our case report, PSARP was the
preferred surgical approach for the repair of anorectal
malformation in six of the nine cases presented.
In our detected cases with the co-occurrence of the
VACTERL association and MRKH syndrome sparse
information exist regarding treatment of the vaginal
aplasia. This can be attributed to a lack of follow-up in
reported cases. Non-surgical creation of a neovagina is
the preferred treatment option according to ACOG [32].
Treatment of MRKH with vaginal dilations has been
reported with anatomical and functional success in 90 to
95% of patients [33, 34]. The first-line approach with
vaginal dilations as well as surgical treatment is best
planned when the patient is emotionally mature during
late adolescence or young adulthood. Surgical treatment
is an option in patients who are unsuccessfully treated
with vaginal dilations. Ongoing postoperative vaginal
dilations or vaginal intercourse can maintain adequate
vaginal dimensioning. Several surgical procedures exist
to create a neovagina, such as the Abbe-McIndoe
operation, the Vecchietti procedure, and modifications
of these procedures. No consensus exists on the pre-
ferred surgical technique to achieve the best functional
outcome [35].
Embryopathogenesis and genetics of VACTERL
association and MRKH syndrome
Cases of VACTERL association and MRKH syndrome
co-occurrence are extremely rare, and to-date no unify-
ing cause has been reported in these cases. It is therefore
imperative to consider current knowledge of each entity
when discussing possible etiologies.
Table 1 Co-occurrence of vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/esophageal atresia, renal defect,
and limb defect association and Mayer-Rokitansky-Küster-Hauser syndrome in the literature and two cases from our local center
Authors VACTERL features Uterovaginal
malformation
Other anomalies Karyotype Surgical and neovaginal
procedures
Bowel and/or urogenital
symptoms at follow-upV A C T E R L
Günsąr et al. [75] X X X UVag agenesis Rib anomalies 46,XX PSARP + sigmoid loop
vaginoplasty (one-stage
operation)
5-years old (none)
King et al. [76] X X X X UVagF agenesis Rib anomaly 46,XX NS Died at 3 months of age
Komura et al. [77] X X X X X X UVag agenesis Left facial nerve
palsy, left hearing
impairment, seizures
NS PSARP 3 years (tracheostomy
tube, mosapride for
GERD, carbamazepine
for seizures)
Linke et al. [78] X X X X UVagF agenesis Right esophageal
lung, duodenal atresia
46,XX None Died at 4 weeks of age
Rall et al. [30] X X X X UVagO agenesis Hearing impairment,
right ear tag
46,XX PSARP, modified
Vecchietti technique
3 months after modified
Vecchietti operation
(no vaginal symptoms)
Teo et al. [79] X X X X X UVagF agenesis Bilateral vesico-
ureteric reflux,
overactive bladder
46,XX PSARP NS
Wester et al. [80] X X X X UVagF agenesis None NS ASARP + sigmoid
loop vaginoplasty
(one-stage operation)
18 months (laxatives)
Bjørsum-Meyer et al.
(this report)
X X X X X UVagFO agenesis None 46,XX PSARP, vaginal dilatations 22 years (vaginal
dilatations)
X X X UVag agenesis None 46,XX PSARP 10 years (laxatives)
A anal atresia, ASARP anterior sagittal anorectoplasty, C cardiac anomaly, F fallopian tube, GERD gastroesophageal reflux disease, L limb anomaly, NS not stated,
O unilateral ovary, PSARP posterior sagittal anorectoplasty, R renal and/or radial anomalies, TE tracheoesophageal fistula and/or esophageal atresia, U uterus,
V vertebral anomaly, Vag vagina
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The organ systems affected in VACTERL association
develop at different stages of organogenesis. The verte-
brae develop early (23 to 32 days) in contrast to the for-
mation of anorectal structures, which occur late in
organogenesis (45 to 56 days). With this in mind several
potential explanations need to be considered, as sug-
gested by Stevenson and Hunter [36]: (1) teratogenic
exposure throughout the entire organogenesis, (2) an
inaugural malformation disturbing the development of
other organs (malformation sequence), (3) disturbance
of molecular pathways or single gene mutations involved
in the formation of multiple organ systems, and (4) a
general disturbance of the developmental process (for
example vascular insufficiency). Most cases of VACTERL
association are sporadic (~90%) [37] and high discord-
ance rates in both monozygotic and dizygotic twin pairs
have been reported [38] suggesting the impact of germ-
line genetics to be minor in the majority of cases.
Reports of true familial cases of VACTERL association
(≥3 component features; CFs) are rare; however, the
prevalence of single CFs in relatives of patients with
VACTERL association is ~10% suggesting a genetic eti-
ology to some extent [37, 39]. The deletion of genes in
the Sonic hedgehog pathway (for example SHH, GLI,
and HOXD13) modeled in mice mimics many of the
same malformations as found in VACTERL association,
which have resulted in a profound interest in these genes
[40]. However, only mutations of HOXD13 [41] and
FOXF1 [42, 43] have been reported in humans with
VACTERL association, while SHH and GLI2 mutations
are associated with holoprosencephaly [40]. Further-
more, mutations in ZIC3 have been reported in several
cases of VACTERL association [43–45]. Several copy
number variations (CNVs) have been reported (thor-
oughly reviewed by Brosens et al. [46]), of which recur-
rent de novo CNVs have been reported at 8q24.3 (GLI4)
and 17q23 (TBX2/TBX4). Finally, a few cases of VAC-
TERL association and mitochondrial dysfunction have
been reported [47]. To-date, the only well-established
environmental cause of VACTERL association in
humans is maternal diabetes mellitus [1]. However, ro-
dent models exposed to adriamycin express many
VACTERL-like features supporting the influence of
teratogenic exposures [48]. In contrast to VACTERL
association, the etiology of VACTERL-hydrocephalus is
well established, it is associated with Fanconi anemia
(both recessive and X-linked mutations) [49].
As in the case of VACTERL association, the etiology
of MRKH syndrome/MURCS association remains elu-
sive. Both in utero exposure to teratogens, epigenetics,
and genetics have been considered as possible explana-
tions. Decades ago, MRKH syndrome was thought to be
caused by teratogens such as thalidomide [24]. The idea
of a non-genetic etiology is supported by several reports
of discordance in monozygotic twins [50–53] and re-
cently by a report of a phthalate-induced rodent model
phenocopying MRKH syndrome [54]. However, most in-
vestigations conducted in the last decade have focused
on the search of genetic causes due to increasing reports
of familial clustering suggesting a low-penetrant auto-
somal dominant or polygenic inheritance [55]. Various
promising CNVs have been reported located at 1q21.1
(RBM8A) [56–58], 16p11.2 (TBX6) [59, 60], 17q12
(LHX1, HNF1B) [56–62], as well as 22q11 [56, 57, 63, 64]
associated with DiGeorge syndrome. Although intensively
studied, the outcomes of candidate gene analyses have
generally been sparse [65]. Positive findings from molecu-
lar genetic analyses include mutations in LHX1 [41, 66],
TBX6 [60, 67], RBM8A [67], and WNT9B [68, 69]. Finally,
mutations in WNT4 have been reported in females with
Müllerian aplasia and hyperandrogenism [26, 70, 71],
although it is thought to be an entity that differs
from MRKH syndrome. However, these genetic find-
ings only apply to a small number of patients and a
more general understanding of the etiology of MRKH
syndrome is still needed.
Other syndromes, with known genetic etiology, occa-
sionally sharing features with both VACTERL associ-
ation and MRKH syndrome should also be considered in
the assessment of these patients. These syndromes
mainly include Townes–Brocks (SALL1) [72], CHARGE
(CHD7) [73], Fraser (FRAS1) [74], and DiGeorge syn-
dromes (del22q11) [63, 64].
As mentioned above, several possible etiologies (both
non-genetic and genetic) have to be considered in cases
of VACTERL and MRKH co-occurrence. Furthermore,
the close interspatial relationship between the hindgut,
urogenital sinus, Müllerian ducts, and developing
kidneys could suggest an inaugural malformation and
subsequently disturbed development of other organs
(malformation sequence). With the current knowledge
of genetics in VACTERL association and MRKH syn-
drome only being applicable for a few patients, there is
currently no clinical genetic testing available for the pa-
tients with co-occurrence. However, in cases of familial
occurrence it is relevant to provide genetic counseling
nonetheless. The future elucidation of cause(s) is essen-
tial to ensure a correct interpretation of these multiple
organ syndromes/associations and ultimately to assist a
more precise genetic counseling and adequate treatment
of these patients.
Conclusion
The co-occurrence of the VACTERL association and
MRKH syndrome is extremely rare and we have only de-
tected seven reported cases but added two from our
local surgical center. This group of patients has unusual
phenotypic characteristics. The long-term outcome after
Bjørsum-Meyer et al. Journal of Medical Case Reports  (2016) 10:374 Page 7 of 10
treatment of defects is not well reported. A single
unifying cause is not known and the etiology probably
includes both genetic and non-genetic causes. We stress
the importance of future studies to optimized treatment,
follow-up, and etiology.
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